RCUS - Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
2024-01-30 13:18:21 ET
Earlier this week, Gilead Sciences ( NASDAQ: GILD ) raised its stake in Arcus Arcus Biosciences ( NYSE: RCUS ) to 33% from ~20% by making an additional equity investment of ~$320 million. The new share purchase came priced $21/share, compared to the $15.49 that RCUS shares were trading at on the open market during Tuesday's midday action....
Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?